ClinicalTrials.gov
public full text
Public Domain
Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal Disease
The purpose of this study is to test whether once-weekly prozac therapy leads to reduction in depression in patients requiring kidney dialysis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Identifying and Treating Depression in Hemodialysis Patients#1095876
- Effect of Acupuncture on Hemodialysis Patients#1114692
- Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients#800868
- Pharmacogenetics in Primary Care Psychotropics#805997
- The Impact of Mindfulness-Based Intervention on Psychophysical Health#995463
Record · ID 1102555
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive